Total Payments
$2,217
2020 Payments
$207.89
Companies
20
Transactions
143
Medicare Patients
870
Medicare Billing
$153,231
Payment Breakdown by Category
Food & Beverage$2,098 (94.6%)
Education$104.49 (4.7%)
Gifts$14.40 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,098 | 141 | 94.6% |
| Education | $104.49 | 1 | 4.7% |
| Gift | $14.40 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $674.47 | 51 | $0 (2020) |
| Teva Pharmaceuticals USA, Inc. | $556.22 | 31 | $0 (2020) |
| Otsuka America Pharmaceutical, Inc. | $231.23 | 10 | $0 (2019) |
| Allergan, Inc. | $165.99 | 13 | $0 (2020) |
| Neurocrine Biosciences, Inc. | $107.21 | 7 | $0 (2020) |
| Bausch Health US, LLC | $88.91 | 5 | $0 (2020) |
| Avanir Pharmaceuticals, Inc. | $73.06 | 4 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $49.03 | 3 | $0 (2019) |
| Validus Pharmaceuticals LLC | $47.55 | 3 | $0 (2019) |
| Vanda Pharmaceuticals Inc. | $31.73 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $207.89 | 12 | Teva Pharmaceuticals USA, Inc. ($82.43) |
| 2019 | $875.93 | 55 | Teva Pharmaceuticals USA, Inc. ($290.41) |
| 2018 | $605.90 | 42 | Sunovion Pharmaceuticals Inc. ($222.12) |
| 2017 | $526.78 | 34 | Sunovion Pharmaceuticals Inc. ($245.58) |
All Payment Transactions
143 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/17/2020 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: Central Nervous System | ||||||
| 08/28/2020 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $21.44 | General |
| Category: Central Nervous System | ||||||
| 08/27/2020 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $33.93 | General |
| Category: Central Nervous System | ||||||
| 06/01/2020 | Bausch Health US, LLC | WELLBUTRIN (Drug), APLENZIN | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: NEUROLOGY | ||||||
| 05/27/2020 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $12.57 | General |
| Category: Central Nervous System | ||||||
| 03/10/2020 | Alfasigma USA, Inc. | — | Food and Beverage | In-kind items and services | $11.38 | General |
| 02/27/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: NEUROSCIENCE | ||||||
| 02/10/2020 | Bausch Health US, LLC | APLENZIN (Drug), MIGRANAL | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: NEUROLOGY | ||||||
| 02/06/2020 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: NEUROLOGY | ||||||
| 01/30/2020 | Takeda Pharmaceuticals U.S.A., Inc. | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: NEUROSCIENCE | ||||||
| 01/24/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.14 | General |
| Category: NEUROSCIENCE | ||||||
| 01/10/2020 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: CNS | ||||||
| 12/18/2019 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: Central Nervous System | ||||||
| 12/09/2019 | Bausch Health US, LLC | WELLBUTRIN (Drug), APLENZIN | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: NEUROLOGY | ||||||
| 11/22/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.53 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2019 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: Central Nervous System | ||||||
| 11/18/2019 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: Neuroscience | ||||||
| 11/08/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: CNS | ||||||
| 10/28/2019 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: Central Nervous System | ||||||
| 10/11/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.26 | General |
| Category: NEUROSCIENCE | ||||||
| 10/03/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: CNS | ||||||
| 09/26/2019 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: Central Nervous System | ||||||
| 09/23/2019 | Otsuka America Pharmaceutical, Inc. | ABILIFY MYCITE (Drug) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: PSYCHIATRY | ||||||
| 09/20/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $7.40 | General |
| Category: CNS | ||||||
| 08/30/2019 | Bausch Health US, LLC | WELLBUTRIN (Drug), APLENZIN | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 121 | 432 | $60,155 | $25,544 |
| 2022 | 6 | 149 | 487 | $68,050 | $28,497 |
| 2021 | 6 | 226 | 673 | $86,310 | $48,284 |
| 2020 | 5 | 374 | 979 | $114,020 | $50,907 |
Total Patients
870
Total Services
2,571
Medicare Billing
$153,231
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90834 | Psychotherapy, 45 minutes | Office | 2023 | 16 | 126 | $22,050 | $8,550 | 38.8% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2023 | 27 | 102 | $11,285 | $6,025 | 53.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 36 | 112 | $13,440 | $5,472 | 40.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 23 | 58 | $10,150 | $4,051 | 39.9% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 19 | 34 | $3,230 | $1,447 | 44.8% |
| 90834 | Psychotherapy, 45 minutes | Office | 2022 | 24 | 163 | $26,900 | $10,869 | 40.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 38 | 116 | $13,920 | $5,713 | 41.0% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2022 | 29 | 82 | $9,020 | $4,675 | 51.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 25 | 49 | $8,575 | $3,635 | 42.4% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 22 | 48 | $4,560 | $2,249 | 49.3% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 11 | 29 | $5,075 | $1,356 | 26.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 60 | 232 | $27,840 | $15,172 | 54.5% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2021 | 52 | 181 | $19,910 | $12,157 | 61.1% |
| 90834 | Psychotherapy, 45 minutes | Office | 2021 | 23 | 104 | $15,600 | $8,434 | 54.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 34 | 53 | $9,275 | $5,473 | 59.0% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 42 | 73 | $6,935 | $3,898 | 56.2% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 15 | 30 | $6,750 | $3,149 | 46.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 112 | 374 | $39,720 | $15,400 | 38.8% |
| 90836 | Psychotherapy, 45 minutes | Office | 2020 | 80 | 227 | $24,970 | $14,398 | 57.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 73 | 132 | $18,140 | $7,477 | 41.2% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 84 | 147 | $13,965 | $7,391 | 52.9% |
| 90834 | Psychotherapy, 45 minutes | Office | 2020 | 25 | 99 | $17,225 | $6,240 | 36.2% |
About Dr. Toby Hazan, M.D
Dr. Toby Hazan, M.D is a Psychiatry healthcare provider based in Bloomfield Hills, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/15/2005. The National Provider Identifier (NPI) number assigned to this provider is 1275535650.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Toby Hazan, M.D has received a total of $2,217 in payments from pharmaceutical and medical device companies, with $207.89 received in 2020. These payments were reported across 143 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($2,098).
As a Medicare-enrolled provider, Hazan has provided services to 870 Medicare beneficiaries, totaling 2,571 services with total Medicare billing of $153,231. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Bloomfield Hills, MI
- Active Since 08/15/2005
- Last Updated 02/03/2021
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1275535650
Products in Payments
- LATUDA (Drug) $674.47
- AUSTEDO (Drug) $451.73
- VRAYLAR (Drug) $165.99
- REXULTI (Drug) $120.81
- INGREZZA (Drug) $107.21
- ABILIFY MAINTENA (Drug) $96.06
- NUEDEXTA (Drug) $73.06
- WELLBUTRIN (Drug) $54.41
- Equetro (Drug) $47.55
- VYVANSE (Drug) $38.86
- APLENZIN (Drug) $34.50
- Trintellix (Drug) $33.26
- Fanapt (Drug) $31.73
- SPRAVATO (Drug) $28.65
- NEUROSTAR TMS THERAPY (Device) $27.06
- INVEGA SUSTENNA (Drug) $20.38
- NUPLAZID (Drug) $17.81
- Subvenite (Drug) $14.62
- TRINTELLIX (Drug) $14.53
- ABILIFY MYCITE (Drug) $14.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Bloomfield Hills
Dr. Richard Jackson, M.d, M.D
Psychiatry — Payments: $3.5M
Psychiatry $3.5M
Dr. Jeffrey Kezlarian, Md, MD
Psychiatry — Payments: $15,214
Psychiatry $15,214
Debora Ferguson, Md, MD
Psychiatry — Payments: $13,493
Psychiatry $13,493
Dr. A George, Md, MD
Psychiatry — Payments: $6,376
Psychiatry $6,376
Randy Dean, M.d, M.D
Psychiatry — Payments: $4,023
Psychiatry $4,023
Renee Harris, Md, MD
Psychiatry — Payments: $2,423
Psychiatry $2,423